Hannah Joseph Hospital Ltd
₹ 75.7
11.93%
02 Apr
- close price
About
Incorporated in 2011, Hannah Joseph Hospital Limited is a healthcare provider offering exceptional medical services across various specialties.[1]
Key Points
- Market Cap ₹ 172 Cr.
- Current Price ₹ 75.7
- High / Low ₹ 76.5 / 56.0
- Stock P/E 23.8
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 17.0 %
- ROE 14.8 %
- Face Value ₹ 10.0
Pros
Cons
- Company has a low return on equity of 9.97% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 35.59 | 54.62 | 63.41 | 77.53 | |
| 28.18 | 38.08 | 45.27 | 56.84 | |
| Operating Profit | 7.41 | 16.54 | 18.14 | 20.69 |
| OPM % | 20.82% | 30.28% | 28.61% | 26.69% |
| 2.21 | 0.25 | 0.22 | 0.37 | |
| Interest | 4.79 | 6.43 | 4.80 | 3.47 |
| Depreciation | 7.28 | 9.35 | 8.21 | 7.24 |
| Profit before tax | -2.45 | 1.01 | 5.35 | 10.35 |
| Tax % | 0.00% | 0.00% | 23.93% | 30.34% |
| -2.45 | 1.01 | 4.07 | 7.21 | |
| EPS in Rs | -13.86 | 0.62 | 2.44 | 4.32 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 77% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 10% |
| Last Year: | 15% |
Balance Sheet
Figures in Rs. Crores
| Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 1.77 | 16.35 | 16.70 | 16.70 | 16.70 |
| Reserves | 22.68 | 18.20 | 29.01 | 35.24 | 40.36 |
| 56.79 | 42.95 | 31.66 | 33.58 | 34.21 | |
| 12.64 | 14.64 | 12.60 | 13.77 | 13.31 | |
| Total Liabilities | 93.88 | 92.14 | 89.97 | 99.29 | 104.58 |
| 85.91 | 71.17 | 65.29 | 69.18 | 66.64 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.64 | 0.64 |
| Investments | 0.00 | 0.14 | 0.00 | 0.00 | 0.00 |
| 7.97 | 20.83 | 24.68 | 29.47 | 37.30 | |
| Total Assets | 93.88 | 92.14 | 89.97 | 99.29 | 104.58 |
Cash Flows
Figures in Rs. Crores
| Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 6.54 | 20.81 | 8.03 | 19.40 | |
| -7.72 | -4.96 | -3.61 | -13.58 | |
| 1.73 | -10.43 | -2.63 | -2.89 | |
| Net Cash Flow | 0.56 | 5.43 | 1.79 | 2.94 |
| Free Cash Flow | -1.22 | 17.02 | 5.69 | 7.91 |
| CFO/OP | 105% | 126% | 44% | 109% |
Ratios
Figures in Rs. Crores
| Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 22.15 | 37.15 | 45.88 | 42.23 |
| Inventory Days | 53.51 | 72.90 | 54.00 | 46.77 |
| Days Payable | 176.45 | 135.53 | 102.09 | 90.06 |
| Cash Conversion Cycle | -100.79 | -25.47 | -2.21 | -1.06 |
| Working Capital Days | -80.71 | -83.06 | -11.22 | -21.28 |
| ROCE % | 13.11% | 16.97% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Average Length of Stay (ALOS) Days |
|
||
| Average Revenue Per Occupied Bed (ARPOB) INR |
|||
| Bed Occupancy Rate % |
|||
| Dr NB Neurosurgery Academic Seats Number |
|||
| In-Patient Footfall Number |
|||
| Operational Beds Number |
|||
| Out-Patient Footfall Number |
|||
| Total Medical and Support Manpower Number |
|||
Requires Premium
Requires Premium
Documents
Announcements
-
Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011
18m - Promoter group declared no encumbrance on shares for FY ended March 31, 2026.
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
2d - Dr. Mosesjoseph acquired 46,000 shares (0.203%) on March 30, 2026; holding now 69.41%.
-
Intimation Of Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015
2d - MD Dr. Mosesjoseph acquired 46,000 shares on 30-Mar-2026 for ~Rs.3.2mn; disclosed 31-Mar-2026.
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
30 Mar - Acquirer bought 3,84,000 shares (1.69%) on March 27, 2026; holding rose to 69.21%.
-
Intimation Of Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015
28 Mar - Dr. Mosesjoseph Arunkumar acquired 384,000 Hannah Joseph Hospital shares on-market on 27 March 2026.
Business Profile[1]
Hannah Joseph Hospital Limited (HJHL) is a 150-bed multi-speciality tertiary care hospital based in Madurai, Tamil Nadu, with a dominant focus on Neurosciences, Cardiac Sciences, Psychiatry and Trauma care.